GSK-201663

Study Sponsor: GSK

Study Title

Immunogenicity, reactogenicity and safety study of Pediarix®, Hiberix® and Prevenar 13® co-administered with two different formulations of GSK Biologicals’ HRV vaccine (444563) in healthy infants 6-12 weeks of age

Medicine or Vaccine (generic name)

Rotavirus Vaccine

Sponsor Identification Number

201663

Trial Registry Identification Number(#'s)

NCT03207750

Medical Condition

Infections, Rotavirus

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=201663

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03207750

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-003210-27

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

November 2020